
FDA Approves Axogen’s Avance Nerve Graft, Marking Major Shift in Peripheral Nerve Repair
The U.S. Food and Drug Administration has granted formal approval to Axogen’s Avance Nerve Graft, a move that secures up to 12 years of potential market exclusivity for the company in the United States. The Avance Nerve Graft, a processed…




